Previous Close | 44.66 |
Open | 44.63 |
Bid | 47.43 x 100 |
Ask | 47.61 x 100 |
Day's Range | 44.48 - 48.36 |
52 Week Range | 3.56 - 53.82 |
Volume | |
Avg. Volume | 383,224 |
Market Cap | 1.588B |
Beta (5Y Monthly) | -1.54 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Soleno Therapeutics Inc (NASDAQ:SLNO), a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.
Soleno Therapeutics Inc (NASDAQ:SLNO), a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.
Just because a business does not make any money, does not mean that the stock will go down. For example, Soleno...